| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 9 |
| GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: A4H6G8
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 128 | 130 | PF00675 | 0.649 |
| CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.566 |
| CLV_NRD_NRD_1 | 8 | 10 | PF00675 | 0.510 |
| CLV_PCSK_KEX2_1 | 128 | 130 | PF00082 | 0.637 |
| CLV_PCSK_KEX2_1 | 24 | 26 | PF00082 | 0.463 |
| CLV_PCSK_KEX2_1 | 8 | 10 | PF00082 | 0.515 |
| CLV_PCSK_SKI1_1 | 49 | 53 | PF00082 | 0.448 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.675 |
| DOC_CYCLIN_yCln2_LP_2 | 52 | 58 | PF00134 | 0.631 |
| DOC_PP4_FxxP_1 | 56 | 59 | PF00568 | 0.634 |
| DOC_PP4_FxxP_1 | 82 | 85 | PF00568 | 0.527 |
| DOC_USP7_MATH_1 | 122 | 126 | PF00917 | 0.440 |
| DOC_WW_Pin1_4 | 105 | 110 | PF00397 | 0.435 |
| LIG_14-3-3_CanoR_1 | 24 | 28 | PF00244 | 0.739 |
| LIG_14-3-3_CanoR_1 | 3 | 7 | PF00244 | 0.689 |
| LIG_14-3-3_CanoR_1 | 66 | 70 | PF00244 | 0.408 |
| LIG_14-3-3_CanoR_1 | 9 | 15 | PF00244 | 0.736 |
| LIG_BRCT_BRCA1_1 | 67 | 71 | PF00533 | 0.410 |
| LIG_deltaCOP1_diTrp_1 | 61 | 64 | PF00928 | 0.482 |
| LIG_LIR_Apic_2 | 117 | 122 | PF02991 | 0.450 |
| LIG_LIR_Apic_2 | 79 | 85 | PF02991 | 0.335 |
| LIG_LIR_Nem_3 | 61 | 65 | PF02991 | 0.482 |
| LIG_LIR_Nem_3 | 68 | 74 | PF02991 | 0.363 |
| LIG_Pex14_2 | 56 | 60 | PF04695 | 0.634 |
| LIG_SH2_CRK | 20 | 24 | PF00017 | 0.671 |
| LIG_SH2_CRK | 78 | 82 | PF00017 | 0.426 |
| LIG_SH2_SRC | 115 | 118 | PF00017 | 0.483 |
| LIG_SH2_STAP1 | 78 | 82 | PF00017 | 0.335 |
| LIG_SH2_STAT5 | 46 | 49 | PF00017 | 0.649 |
| LIG_SH3_3 | 91 | 97 | PF00018 | 0.440 |
| LIG_TYR_ITIM | 76 | 81 | PF00017 | 0.447 |
| MOD_CK1_1 | 4 | 10 | PF00069 | 0.693 |
| MOD_CK2_1 | 10 | 16 | PF00069 | 0.734 |
| MOD_Cter_Amidation | 126 | 129 | PF01082 | 0.728 |
| MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.632 |
| MOD_GlcNHglycan | 9 | 12 | PF01048 | 0.465 |
| MOD_GSK3_1 | 34 | 41 | PF00069 | 0.677 |
| MOD_LATS_1 | 32 | 38 | PF00433 | 0.681 |
| MOD_N-GLC_1 | 122 | 127 | PF02516 | 0.643 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.653 |
| MOD_NEK2_1 | 45 | 50 | PF00069 | 0.644 |
| MOD_NEK2_1 | 64 | 69 | PF00069 | 0.378 |
| MOD_PKA_2 | 2 | 8 | PF00069 | 0.661 |
| MOD_PKA_2 | 23 | 29 | PF00069 | 0.767 |
| MOD_PKA_2 | 65 | 71 | PF00069 | 0.378 |
| MOD_ProDKin_1 | 105 | 111 | PF00069 | 0.434 |
| TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.344 |
| TRG_ER_diArg_1 | 128 | 130 | PF00400 | 0.462 |
| TRG_ER_diArg_1 | 23 | 25 | PF00400 | 0.757 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1IJC2 | Leptomonas seymouri | 91% | 100% |
| A0A0S4JUP5 | Bodo saltans | 65% | 100% |
| A0A1X0NV45 | Trypanosomatidae | 79% | 100% |
| A0A3Q8I7X8 | Leishmania donovani | 98% | 100% |
| A4HUW7 | Leishmania infantum | 98% | 100% |
| D0A7J2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 70% | 100% |
| E9ANJ6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
| Q4QH30 | Leishmania major | 98% | 100% |
| V5DT78 | Trypanosoma cruzi | 73% | 100% |